Capucine Baldini

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)

Frédéric Bigot, Eduardo Castañón, Capucine Baldini et al. · European Journal of Cancer · 2017 · 225 citations

Life Sciences, Immunology, Oncology +12

Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation

Marie-Léa Gauci, Émilie Lanoy, Stéphane Champiat et al. · Clinical Cancer Research · 2018 · 143 citations

Medicine, Oncology, Pharmacotherapy +15

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson, Alexandre Maria, F. Poizeau et al. · Journal for ImmunoTherapy of Cancer · 2019 · 106 citations · Full text

Life Sciences, Immunology, Oncology +17

Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

Layal Rached, Ariane Laparra, Madona Sakkal et al. · Cancer Treatment Reviews · 2024 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17